XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 33,700 $ 9,594
Accounts receivable (net of allowance of $168 and $156 at June 30, 2025 and December 31, 2024, respectively) 8,981 10,662
Inventories 466 1,231
Prepaids and other current assets 4,606 2,856
Total current assets 47,753 24,343
Property, plant and equipment, at cost 35,967 301,417
Less accumulated depreciation (25,910) (288,784)
Property, plant and equipment, net 10,057 12,633
Operating lease right-of-use assets 16,210 17,434
Deferred income taxes, net 399 5,609
Other assets 1,816 1,824
Total assets 76,235 61,843
Current liabilities:    
Accounts payable 3,884 4,808
Accrued compensation and benefits 3,907 4,234
Other accrued expense 4,087 7,264
Contract liabilities 8,852 8,689
Total current liabilities 20,730 24,995
Long-term pension liabilities   11,764
Long-term operating lease liabilities 16,155 17,379
Other post-employment benefits 854 880
Other liabilities 12 12
Total liabilities 37,751 55,030
Commitments and contingencies (Note 10)
Shareholders' equity:    
Preferred stock, $0.01 par value; Authorized 2,000,000 shares; none issued
Treasury stock, Series A, at cost; 478,465 shares held at June 30, 2025 and December 31, 2024 (13,443) (13,443)
Additional paid-in capital 494,563 494,563
Accumulated other comprehensive loss 355 (36,523)
Accumulated deficit (443,049) (437,842)
Total shareholders’ equity 38,484 6,813
Total liabilities and shareholders’ equity 76,235 61,843
Series A [Member]    
Shareholders' equity:    
Common stock, $0.01 par value; Authorized 31,250,000 shares 52 52
Series B [Member]    
Shareholders' equity:    
Common stock, $0.01 par value; Authorized 31,250,000 shares $ 6 $ 6